Journal of Nutrition OpenSOurce Diets- www.ResearchDiets.com

Home Help [Feedback] [For Subscribers] [Archive] [Search]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garg, M. L.
Right arrow Articles by Wills, R. B. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garg, M. L.
Right arrow Articles by Wills, R. B. H.

© 2003 The American Society for Nutritional Sciences J. Nutr. 133:1060-1063, April 2003


Human Nutrition and Metabolism
Research Communication

Macadamia Nut Consumption Lowers Plasma Total and LDL Cholesterol Levels in Hypercholesterolemic Men

Manohar L. Garg2, Robert J. Blake and Ron B. H. Wills*

Nutrition & Dietetics, School of Health Sciences, Faculty of Health, University of Newcastle, Callaghan, NSW, Australia and * Centre for Advancement of Food Technology and Nutrition, University of Newcastle, Ourimbah, NSW, Australia

2To whom correspondence should be addressed. E-mail: manohar.garg{at}newcastle.edu.au.


    ABSTRACT
 TOP
 ABSTRACT
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 
This study was conducted to assess the cholesterol-lowering potential of macadamia nuts. Seventeen hypercholesterolemic men (mean age 54 y) were given macadamia nuts (40–90 g/d), equivalent to 15% energy intake, for 4 wk. Plasma total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides and homocysteine concentrations and the fatty acid composition of plasma lipids were determined before and after treatment. Plasma MUFA 16:1(n-7), 18:1(n-7) and 20:1(n-9) were elevated after intervention with macadamia nuts. Plasma (n-6) and (n-3) PUFA concentrations were unaffected by macadamia nut consumption. Plasma total cholesterol and LDL cholesterol concentrations decreased by 3.0 and 5.3%, respectively, and HDL cholesterol levels increased by 7.9% in hypercholesterolemic men after macadamia nut consumption. Plasma triglyceride and homocysteine concentrations were not affected by treatment. Macadamia nut consumption was associated with a significant increase in the relative intake of MUFA and a reduced relative intake of saturated fatty acids and PUFA. This study demonstrates that macadamia nut consumption as part of a healthy diet favorably modifies the plasma lipid profile in hypercholesterolemic men despite their diet being high in fat.


KEY WORDS: • macadamia nuts • plasma cholesterol • hypercholesterolemia • LDL cholesterol • HDL cholesterol

Dietary factors known to alleviate plasma cholesterol levels in humans include (n-6) and (n-3) PUFA, dietary fiber and plant sterols. (n-6) PUFA, although associated with cholesterol-lowering effects, serve as a substrate for the formation in the platelets of thromboxane A2, which is a potent pro-aggregatory substance (1 ,2 ). Additionally, both (n-3) and (n-6) PUFA increase requirements for antioxidants to protect them from auto-oxidation and minimize oxidative damage in the body (35 ). MUFA present in olive, sunola and canola oils have been shown to be cholesterol-neutral or even cholesterol-lowering in several studies (6 ,7 ). MUFA also reduce demands for antioxidants, and thus may alleviate oxidative stress in vivo (810 ). Margarines and spreads enriched with MUFA and/or plant sterols with health claims to reduce plasma cholesterol concentrations are available in the supermarkets. The research on whole foods, containing factors with hypocholesterolemic potential, is scanty.

The macadamia nut, a tree nut native to Australia, contains ~75 g fat/100 g nuts and >85% of its energy from fat. Macadamia nuts contain higher levels of MUFA than any other food source known to date (>60 g/100 g of edible whole nuts) (11 ). A recent study has demonstrated that macadamia nuts are a rich source (1.28 mg/g lipid) of plant sterols (12 ). Diets containing high MUFA-rich foods have been shown to reduce plasma LDL cholesterol levels without any detrimental effects on HDL cholesterol (1315 ). Recent studies have demonstrated that constituents other than fats in tree nuts may be responsible for their cholesterol-lowering effects (16 ). Curb et al. (17 ) demonstrated that a macadamia nut–based diet is nearly as effective as a moderately low fat diet (American Heart Association Step 1 diet) in reducing total plasma cholesterol and LDL cholesterol, in comparison to a typical American diet. The present study was carried out to examine the effects of replacing 15% energy intake by macadamia nuts (40–90 g/d) on plasma lipid and homocysteine levels as well as fatty acid composition in hypercholesterolemic men.


    SUBJECTS AND METHODS
 TOP
 ABSTRACT
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 
Subjects.

Hypercholesterolemic men (n = 17; plasma cholesterol 6.1–7.5 mmol/L) were recruited. All subjects maintained their regular lifestyles, especially their physical activity. The Human Research Ethics Committee of the University of Newcastle approved these studies. All subjects signed an information and consent form agreeing to participate.

Intervention trial.

Freshly roasted, lightly salted and/or unsalted (subjects were allowed to choose) macadamia nut kernels (Macadamia integrifolia) were purchased from the Suncoast Gold Macadamias Ltd. (Queensland, Australia). Diabetics, smokers and people with thyroid disorders or high blood pressure or on cholesterol-lowering drug/nutritional therapies were excluded from the study. Subjects consuming >10 standard drinks/wk were also excluded. The intervention phase consisted of a 4-wk period of consuming macadamia nuts contributing ~15% of the total daily energy intake. The absolute amount of macadamia nuts consumed ranged from 40 to 90 g/d, depending on subject’s energy intake. One-day supplies of nuts were packed in separate moisture-free bags. An extra color-coded bag of macadamia nuts was given to the subjects to share with family and friends to improve compliance. Compliance was measured by the nut count-back method and by examining the incorporation of 16:1(n-7) into plasma lipids after the 4-wk intervention period. Subjects were instructed to maintain their usual diet and level of physical activity. A 3-d food diary (including at least 1 d from the weekend) was completed by the subjects at the start (1 wk before commencement of the intervention) and toward the end (during wk 4) of the intervention period. Dietary records were analyzed for nutrient and energy intakes by a computer-based program (Foodworks 2.10.136, Xyris Software, Australia). Blood samples were collected from fasting subjects by venipuncture at entry to the study and at the conclusion of the intervention.

Plasma was separated from red blood cells within 1 h of collection by centrifugation at 3000 x g for 10 min and analyzed for total cholesterol, HDL cholesterol and triglycerides by colorimetric enzymatic assays using a Hitachi autoanalyzer (Hitachi 747; Hitachi-Boehringer, Mannheim, Germany). LDL cholesterol values were calculated. Aliquots of plasma were frozen at -80°C for determination of homocysteine and fatty acid concentrations.

Fatty acid analysis.

The lipid profile of the plasma was determined according to a modification of the method of Lepage and Roy (18 ). Briefly, 100 µL of plasma was mixed with 2 mL of methanol:toluene (4:1 v/v) containing 4 mg/L of 21:0 as an internal standard, and 0.12 mg/L butylated hydroxytoluene as an antioxidant, in a glass culture tube. This was followed by the slow addition of 200 µL acetyl chloride with continuous shaking. The samples were methylated by heating at 100°C for 60 min and extracted samples stored in glass vials sealed with a Teflon-lined cap for subsequent analysis by gas chromatography.

Fatty acid methyl esters (FAME) were quantified using a Hewlett–Packard 6890 gas chromatograph (Hewlett–Packard, Palo Alto, CA) equipped with a 30 m x 250 µm x 0.25 µm capillary column (J&W DB-225; J&W Scientific, Folsom, CA) flame ionization detector (19 ). Chromatographic conditions were as follows: inlet temperature, 250°C; inlet pressure, 97.5 kPa; split ratio, 20:1; carrier gas as hydrogen (ultrahigh purity) at 1.6 mL/min. The chromatographic conditions were as follows: initial temperature of 170°C held for 2 min; ramped to 190°C at a rate of 10°C/min; held there for 1 min; ramped to 220°C at a rate of 3°C/min; and held at 220°C for 15 min. FAME were identified and quantified by comparison with authentic FAME standards (Nu-Chek Prep, Elysian, MN).

Homocysteine assay.

Plasma total homocysteine was measured by use of a commercially available assay kit (Drew Scientific DS30 Hcy homocysteine assay kit, Cumbria, UK) (20 ). After extraction, the samples were analyzed on a Hewlett–Packard 1100 Series HPLC system by use of a Hewlett–Packard 1046A programmable fluorescence detector, and Hewlett–Packard Chem Stations Rev. A:08.03 [847] software. The chromatographic conditions were as follows: column; Hewlett–Packard ODS Hypersil, 5 µm x 125 mm x 4 mm; column temperature, 36°C; mobile phase, 50 mmol/L KCl; 10 mmol/L heptanesulfonic acid sodium salt; 13 mmol/L HCl, 2% (v/v) methanol; flow rate, 1.0 mL/min; injection volume, 20 µL; excitation, 400 nm; emission, 503 nm.

Statistical analysis.

The means ± SEM are presented for each measurement. A two-tailed, paired Student’s t test was used to compare baseline values with postintervention values. Differences were considered significant at P < 0.05.


    RESULTS
 TOP
 ABSTRACT
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 
Total energy and protein intakes were similar at baseline and postintervention in all the hypercholesterolemic subjects (Table 1 ). Fat intake, as a percentage of energy intake, was significantly increased after intervention with macadamia nuts, with a concomitant reduction in carbohydrate intake (starch and sugars). As expected, the relative MUFA intake increased significantly in subjects after 4 wk of eating macadamia nuts, suggesting a high degree of compliance. The dietary intakes of saturated fatty acids (SFA) and PUFA as a percentage of fat intake were significantly reduced when the men consumed macadamia nuts. Dietary fiber, cholesterol intake and alcohol consumption were similar at baseline and after intervention.


View this table:
[in this window]
[in a new window]
 
TABLE 1 Nutrient intakes, body weights and body mass indexes (BMI) of hypercholesterolemic men at baseline (1 wk before intervention) and postintervention (during wk 4) with macadamia nuts (equivalent to 15% daily energy intake)1

 
The mean age of the hypercholesterolemic men was 54 y and they had a body mass index (BMI, kg/m2) of 26.24 ± 0.77 at baseline. The BMI was significantly reduced after 4 wk of intervention with macadamia nuts (Table 1) .

Plasma MUFA such as 16:1(n-7), 18:1(n-7) and 20:1(n-9) were significantly elevated in all subjects after macadamia nut consumption, further confirming the high degree of compliance (Table 2 ). The concentration of palmitoleic acid, 16:1(n-7), for which the unique dietary source is macadamia nut, was elevated by treatment (Table 2) . PUFA were not affected by the intervention. Some SFA (20:0 and 22:0) were elevated following intervention.


View this table:
[in this window]
[in a new window]
 
TABLE 2 Plasma fatty acid concentrations of hypercholesterolemic men at baseline and 4 wk postintervention with macadamia nuts (equivalent to 15% daily energy intake)1

 
The hypercholesterolemic men had a plasma total cholesterol concentration of 6.51 ± 0.15 mmol/L at baseline. None was on a lipid-lowering drug therapy. After 4 wk of consuming macadamia nuts, plasma total and LDL cholesterol concentrations were significantly reduced and HDL cholesterol was increased (Table 3 ). These alterations in plasma lipids resulted in a significant reduction in the total to HDL cholesterol ratio. Plasma triglyceride and homocysteine concentrations were not influenced by macadamia nut consumption (Table 3) .


View this table:
[in this window]
[in a new window]
 
TABLE 3 Plasma lipid and homocysteine concentrations of hypercholesterolemic men at baseline and 4 wk postintervention with macadamia nuts (equivalent to 15% daily energy intake)1

 

    DISCUSSION
 TOP
 ABSTRACT
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 
Hypercholesterolemia is a major risk factor for coronary artery disease; reducing plasma cholesterol levels, particularly LDL cholesterol, reduces the risk of this disease. Dietary strategies known to reduce cholesterol levels include a reduction in total fat and saturated fat intake and increased intake of dietary fiber. Recently it has been suggested that the quality, rather than the quantity, of dietary fat may be a more important determinant of the blood cholesterol level. Minor dietary constituents such as plant sterols, thiol compounds in garlic and other herbs and vitamin (niacin and vitamin C) supplements have been shown to lower circulating cholesterol levels. The effect of eating whole foods rich in macro- and micronutrients responsible for cholesterol lowering has not been investigated. Macadamia nuts, which are rich in MUFA, plant sterols and fiber, offer an opportunity to examine the hypocholesterolemic potential of consuming whole nut kernels as part of a healthy diet.

The results presented suggest that consumption of macadamia nuts, despite their being high in fat, has no detrimental effects on plasma cholesterol levels. A randomized crossover trial in a free-living population fed a macadamia nut–based monounsaturated fat diet, demonstrated a 5% reduction in plasma cholesterol compared to a "typical American" diet high in saturated fat (17 ). In the present study, macadamia nut consumption was associated with a proportional increase in MUFA intake and proportional reductions in PUFA and SFA consumption. These changes could contribute to the cholesterol-lowering potential of macadamia nuts in individuals with higher than normal plasma cholesterol (>6.0 mmol/L), as evident from the data presented here. In the present study, the beneficial effects were 2-fold, that is, a reduction in total and LDL cholesterol and an increase in HDL cholesterol, resulting in a 7.9% reduction in the plasma total to HDL cholesterol ratio. In contrast, previous studies (17 ,21 ) reported no difference in HDL cholesterol after macadamia nut intervention compared to individuals consuming the AHA Step 1 or high carbohydrate diets. The total fat and monounsaturated fat intakes increased during macadamia nut intervention in the present study, which may be responsible for the increase in HDL cholesterol. It was previously shown that a reduction in fat intake lowers HDL cholesterol levels and vice versa (2224 ) and that inclusion of MUFA in low fat diets may reduce HDL cholesterol less than the low fat diet alone (25 ).

PUFA in the plasma were not affected by macadamia nut intervention. MUFA, especially 16:1(n-7) from macadamia nuts, were incorporated into plasma lipids, indicating that the subjects were compliant. Previous studies did not report fatty acid profiles of plasma after intervention with macadamia nuts. This study demonstrated that because 16:1(n-7) is uniquely present at substantially higher levels in macadamia nuts than in any other food source, the plasma level of this fatty acid is a reliable measure of compliance. One question that was previously raised (16 ) is whether nuts contain constituents other than fats that may affect blood cholesterol. A recent analysis of the published data on the effects of incorporating tree nuts on plasma lipids and lipoproteins revealed that when subjects consumed test diets containing nuts, there was an ~25% greater cholesterol-lowering response than that predicted by the equations. This suggests that there are non–fatty acid components in nuts with cholesterol-lowering effects. In this respect, it is noteworthy that macadamia nuts contain substantial levels of plant sterols (1.28 mg/g lipid), which were previously shown to inhibit cholesterol absorption (26 ,27 ). Plant sterols contributed by macadamia nuts were 50–115 mg/d, depending on subjects’ energy intakes. It has been established that plant sterols are effective as cholesterol-lowering agents only when present in gram quantities (26 ,27 ). However, the possibility of synergies between MUFA, fiber, polyphenols and plant sterols in whole macadamia nuts to reduce plasma cholesterol cannot be ruled out.

In summary, inclusion of macadamia nuts as part of a healthy diet favorably altered the plasma lipid profile, despite an increase in the dietary fat content. Interestingly, the beneficial effects were observed in a cohort (hypercholesterolemics) in need of reducing plasma cholesterol. Indeed, the extent of reduction in plasma cholesterol in a short-term intervention of 4 wk is not sufficient to exempt patients from additional drug/nutritional interventions, but may be of value as an adjunct to current known cholesterol-lowering therapies. An intervention trial involving macadamia nut consumption for a longer duration (>=6 mo) is warranted. Regardless, the degree of alterations in the blood lipid profile extends beyond those observed with an AHA Step 1 diet because of the dual beneficial effects on LDL and HDL cholesterol. These results, in association with previously published reports on the beneficial effects of tree nuts on biomarkers of coronary artery disease, allow a prudent recommendation for the inclusion of macadamia nuts as part of a heart-healthy diet.


    FOOTNOTES
 
1 Supported by a grant from the Horticultural Research and Development Corporation of Australia. Back

3 Abbreviations used: BMI, body mass index; FAME, fatty acid methyl esters; SFA, saturated fatty acids. Back

Manuscript received 7 November 2002. Revision accepted 7 January 2003.


    LITERATURE CITED
 TOP
 ABSTRACT
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 

1. Lahoz, C., Alonso, R., Ordovas, J. M., Lopezfarre, A., Deoya, M. & Mata, P. (1997) Effects of dietary fat saturation on eicosanoid production, platelet aggregation and blood pressure. Eur. J. Clin. Nutr. 27:780-787.

2. Okita, M., Sasagawa, T., Ohta, Y., Kaneyuki, T. & Suzuki, K. (2001) Effect of arachidonic acid-rich oil on lipids and arachidonate metabolites in ethanol-treated rats. Prostaglandins Leukot. Essent. Fatty Acids 64:273-279.[Medline]

3. Bulur, H., Ozdemirler, G., Oz, B., Toker, G., Ozturk, M. & Uysal, M. (1995) High cholesterol diet supplemented with sunflower seed oil but not olive oil stimulates lipid peroxidation in plasma, liver, and aorta of rats. J. Nutr. Biochem. 6:547-550.

4. Nair, P. P., Judd, J. T., Berlin, E., Taylor, P. R., Shami, S., Sainz, E. & Bhagavan, H. N. (1993) Dietary fish oil induced changes in the distribution of {alpha}-tocopherol, retinol, and ß-carotene in plasma, red blood cells and platelets: modulation by vitamin E. Am. J. Clin. Nutr. 58:98-102.[Abstract/Free Full Text]

5. Karlsson, J. (1997) Exercise, muscle metabolism and the antioxidant defense. Simopoulos, A. P. Pavlou, K. N. eds. World Reviews on Nutrition & Dietetics 82:781-100 Karger Basel, Switzerland. .

6. Grundy, S. M. (1986) Comparison of monounsaturated fatty acids and carbohydrates for lowering plasma cholesterol. N. Engl. J. Med. 314:745-748.[Abstract]

7. Kris-Etherton, P. M., Pearson, T. A., Wan, Y., Hargrove, R. L., Moriarty, K., Fishell, V. & Etherton, T. D. (1999) High-monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations. Am. J. Clin. Nutr. 70:1009-1015.[Abstract/Free Full Text]

8. Lopez-Miranda, J., Gomez, P., Castro, P., Marin, C., Paz, E., Bravo, M. D., Blanco, J., Jimenez-Pereperez, J., Fuentes, F. & Perez-Jimenez, F. (2000) Mediterranean diet improves low density lipoprotein susceptibility to oxidative modifications. Med. Clin. 115:361-365.

9. Parthasarathy, S., Khoo, J. C., Miller, E., Barnett, J., Witztum, J. L. & Steinberg, D. (1990) Low density lipoprotein enriched in oleic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 87:3894-3898.[Abstract/Free Full Text]

10. Berry, E. M., Eisenberg, S., Haratz, D., Friedlander, Y., Norman, Y., Kaufmann, N. A. & Stein, Y. (1991) Effects of diets rich in monounsaturated fatty acids on plasma lipoproteins—the Jerusalem Nutrition Study: high MUFAs vs high PUFAs. Am. J. Clin. Nutr. 53:899-907.[Abstract/Free Full Text]

11. Holland, B., Unwin, I. D. & Buss, D. H. (1992) Fruits and Nuts: The Composition of Foods, McCance and Widdowson’s 5th ed. 1992 Xerox Ventura Cambridge, UK.

12. Kaijser, A., Dutta, P. & Savage, G. (2000) Oxidative stability and lipid composition of macadamia nuts grown in New Zealand. Food Chem. 71:67-70.

13. Rajaram, S., Burke, K., Connell, B., Myint, T. & Sabate, J. (2001) A monounsaturated fatty acid-rich pecan-enriched diet favorably alters the serum lipid profile of healthy men and women. J. Nutr. 131:2275-2279.[Abstract/Free Full Text]

14. Mensink, R. P. & Katan, M. B. (1987) Effect of monounsaturated fatty acids versus complex carobohydrates on high-density lipoprotein cholesterol in healthy men and women. Lancet 1:122-125.[Medline]

15. Colquhoun, D. M., Moores, D., Somerset, S. M. & Humphries, J. A. (1992) Comparison of the effects on lipoproteins and apolipoproteins of a diet high in monounsaturated fatty acids, enriched with avocado, and a high-carbohydrate diet. Am. J. Clin. Nutr. 56:671-677.[Abstract/Free Full Text]

16. Kris-Etherton, P. M., Yu-Poth, S., Sabate, J., Ratcliffe, H. E., Zhao, G. & Etherton, T. D. (1999) Nuts and their bioactive constituents: effects on serum lipids and other factors that affect disease risk. Am. J. Clin. Nutr. 70(suppl.):504S-511S.[Abstract/Free Full Text]

17. Curb, J. D., Wergowske, G., Dobbs, J. C., Abbott, R. D. & Huang, B. (2000) Serum lipid effects of a high-monounsaturated fat diet based on macadamia nuts. Arch. Int. Med. 160:1154-1158.

18. Lepage, G. & Roy, C. C. (1986) Direct trans-esterification of all classes of lipid in a one-step reaction. J. Lipid Res. 27:114-120.[Abstract]

19. Nair, S.S.D., Leitch, J. W., Falconer, J. & Garg, M. L. (1999) Cardiac n-3 non-esterified fatty acids are selectively increased in fish oil fed pigs following myocardial ischemia. J. Nutr. 129:1518-1523.[Abstract/Free Full Text]

20. Araki, A. & Sako, Y. (1987) Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. 422:43-52.[Medline]

21. Colquhoun, D. M., Humphries, J. A., Moores, D. & Somerset, S. M. (1996) Effects of a macadamia nut enriched diet on serum lipids and lipoproteins compared to a low fat diet. Food Australia 48:216-222.

22. Katan, M. B. (1998) Effect of low fat diets on plasma high density lipoprotein concentrations. Am. J. Clin. Nutr. 67(suppl.):573S-576S.[Abstract]

23. Terpstra, A.H.M., van den Berg, P., Jansen, H., Beynen, A. C. & van Tol, A. (2000) Decreasing dietary fat saturation lowers HDL-cholesterol and increases hepatic HDL binding in hamsters. Br. J. Nutr. 83:151-159.[Medline]

24. Wolf, G. (1996) High fat high cholesterol diet raises plasma HDL cholesterol—studies on mechanism of this effect. Nutr. Rev. 54:34-35.[Medline]

25. Morgan, S. A., O’Dea, K. & Sinclair, A. J. (1997) A low-fat diet supplemented with monounsaturated fat results in less HDL-cholesterol lowering than a very low fat diet. J. Am. Diet. Assoc. 97:151-156.[Medline]

26. Ikeda, I. & Sugano, M. (1998) Inhibition of cholesterol absorption by plant sterols for mass intervention. Curr. Opin. Lipidol. 9:527-531.[Medline]

27. Miettinen, T. A., Vuoristo, M., Nissinen, M., Jarvinen, H. J. & Gylling, H. (2000) Serum, biliary, and fecal cholesterol and plant sterols in colectomized patients before and during consumption of stanol ester margarine. Am. J. Clin. Nutr. 71:1095-1102.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
J. Nutr.Home page
N. R. Matthan, A. Dillard, J. L. Lecker, B. Ip, and A. H. Lichtenstein
Effects of Dietary Palmitoleic Acid on Plasma Lipoprotein Profile and Aortic Cholesterol Accumulation Are Similar to Those of Other Unsaturated Fatty Acids in the F1B Golden Syrian Hamster
J. Nutr., February 1, 2009; 139(2): 215 - 221.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. E. Griel, Y. Cao, D. D. Bagshaw, A. M. Cifelli, B. Holub, and P. M. Kris-Etherton
A Macadamia Nut-Rich Diet Reduces Total and LDL-Cholesterol in Mildly Hypercholesterolemic Men and Women
J. Nutr., April 1, 2008; 138(4): 761 - 767.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. Mukuddem-Petersen, W. Oosthuizen, and J. C. Jerling
A Systematic Review of the Effects of Nuts on Blood Lipid Profiles in Humans
J. Nutr., September 1, 2005; 135(9): 2082 - 2089.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garg, M. L.
Right arrow Articles by Wills, R. B. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garg, M. L.
Right arrow Articles by Wills, R. B. H.


Home Help [Feedback] [For Subscribers] [Archive] [Search]
Copyright © 2003 by American Society for Nutrition